High prevalence of peripheral arterial disease in hypertensive patients: The Evaluation of Ankle-Brachial Index in Hungarian Hypertensives screening program

Journal of Hypertension

Volumn 30, Issue 8, 2012, Pages 1526-1532

  Farkas, Katalin ^a   Járai, Zoltán ^b   Kolossváry, Endre ^a   Ludányi, Andrea ^c   Clement, Denis L ^d   Kiss, István ^a  

^a Szent Imre Hospital   (Hungary)

^b Department of Cardiology   (Hungary)

^c EGIS PHARMACEUTICALS LTD   (Hungary)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

ankle brachial index; cardiovascular risk; hypertension; peripheral arterial disease

Indexed keywords

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD ANALYSIS; BLOOD PRESSURE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUNGARY; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING;

EID: 84863832625     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283559a6a     Document Type: Article

References (34)

1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part II. Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104:2855-2864.
3. Brindle P, Beswick AD, Fahey T, Ebrahim SB. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006; 92:1752-1759.
4. Ankle Brachial Index Collaboration. Ankle Brachial Index combined with Framingham Risk Score to predict cardiovascular events and mortality. JAMA 2008; 300:197-208.
5. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71:510-515.
6. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995; 91:1472-1479.
7. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110:738-743.
8. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, Wahlberg E. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007; 45:1185-1191.
9. Belch JJF, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Int Med 2003; 163:884-892.
10. Diehm C, Lange S, Darius H, Pittrow D, Stritzky B, Tepohl G, et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006; 27:1743-1749.
11. Wild SH, Byrne CD, Smith FB, Lee AJ, Fowkes FGR. Low Ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabetes Care 2006; 29:637-642.
12. Lamina C, Meisinger C, Heid IM, Löwel H, Rantner B, Koenig W, Kronenberg F. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. Eur Heart J 2006; 27:2580-2587.
13. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes. Arterioscler Thromb Vasc Biol 2005; 25:1463-1469.
14. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine and Biology, and the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Circulation 2006; 113:463-654.
15. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45:S5A-S67A.
16. Jager KJ, Zoccali C, Macleod A, Dekker FW. Confounding: what it is and how to deal with it. Kidney Int 2008; 73:256-260.
17. Chen JJ, Lee CH, Lin LY, Liau CS. Determinants of lower extremity amputation or revascularization procedure in patients peripheral artery diseases: a population-based investigation. Angiology 2010 [Epub ahaed of print].
18. Kearney P, Whelton M, Reynolds K, Whelton P, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-19.
19. Flu HC, Tamsma JT, Lindeman JH, Hamming JF, Lardenoye JH. A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD. Eur J Vasc Endovasc Surg 2010; 39:70-86.
20. Kannel WB, Vasan RS. Assessment of cardiovascular risk and choice of antihypertensive therapy. Curr Hypertens Rep 2004; 6:346-351.
21. Mancia G, Grassi G. The new European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines. Ther Adv Cardiovasc Dis 2008; 2:5-12.
22. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs. Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005; 165:2644-2650.
23. Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women. Circulation 2005; 112:25-31.
24. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008; 118:2243-2251.
25. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999; 19:538-545.
26. Holland-Letz T, Endres HG, Biedermann S, Mahn M, Kunert J, Groh S, et al. Reproducibility and reliability of the ankle-brachial index as assessed by vascular experts, family physicians and nurses. Vasc Med 2007; 12:105-112.
27. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation 1997; 96:44-49.
28. Ramsey LE. Intermittent claudication in hypertensive men. JR Coll Physicians Lond 1979; 13:100-102.
29. Newman AB, Sutton-Tyrrell K, Rutan GH, Locher J, Kuller LH. Lower extremity arterial disease in elderly subjects with systolic hypertension. J Clin Epidemiol 1991; 44:15-20.
30. Greenland P, Alpert JS, Beller GA, et al. American College of Cardiology Foundation; American Heart Association 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010; 56:e50-e103.
31. Korhonen PE, Syvänen KT, Vesalainen RK, Kantola IM, Kautiainen H, Järvenpää S, Aarnio PT. Ankle-brachial index is lower in hypertensive than in normotensive individuals in a cardiovascular risk population. J Hypertens 2009; 27:2036-2043.
32. Morillas P, Cordero A, Bertomeu V, Gonzalez-Juanatey JR, Quiles J, Guindo J, et al. Prevalence of Peripheral Arterial Disease in Patients with Acute Coronary Syndrome (PAMISCA) Investigators. Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens 2009; 27:341-347.
33. Bavry AA, Anderson RD, Gong Y, Denardo SJ, Cooper-Dehoff RM, Handberg EM, Pepine CJ. Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/ Trandolapril STudy. Hypertension 2010; 55:48-53.
34. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115:2761-2788.